
CIK 0001827090
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | Mohammed FaizInterim CFO | Grant or award | A | — 63.5K sh | Sep 2, 2026 traded Sep 1, 2026 | |
Corcoran DanielSVP and General Counsel |
Tax withholding |
| F |
| $46K 7,893 sh |
| Jun 2, 2026 traded Jun 1, 2026 |
| 21 | Anhalt RonaChief Human Resources Officer | Option exercise | M | — 7,147 sh | Jun 2, 2026 traded Jun 1, 2026 |
| 9 | Anhalt RonaChief Human Resources Officer | Option exercise | M | — 7,147 sh | Jun 2, 2026 traded Jun 1, 2026 |
| 9 | Corcoran DanielSVP and General Counsel | Option exercise | M | — 14.9K sh | Jun 2, 2026 traded Jun 1, 2026 |
| 13 | Anhalt RonaChief Human Resources Officer | Tax withholding | F | $13K 2,241 sh | Jun 2, 2026 traded Jun 1, 2026 |
| 21 | Corcoran DanielSVP and General Counsel | Option exercise | M | — 14.9K sh | Jun 2, 2026 traded Jun 1, 2026 |
| 9 | Corcoran DanielSVP and General Counsel | Option exercise | M | — 7,941 sh | Jun 2, 2026 traded Jun 1, 2026 |
| 17 | Corcoran DanielSVP and General Counsel | Option exercise | M | — 7,941 sh | Jun 2, 2026 traded Jun 1, 2026 |
| 17 | Corcoran DanielSVP and General Counsel | Tax withholding | F | $25K 4,210 sh | Jun 2, 2026 traded Jun 1, 2026 |
| 9 | Bedi ArjunDirector | Grant or award | A | — 33.2K sh | May 15, 2026 traded May 14, 2026 |
| 9 | Bedi ArjunDirector | Option exercise | M | — 5,547 sh | May 15, 2026 traded May 14, 2026 |
| 9 | Reynders John V WDirector, Chief Financial Officer | Option exercise | M | — 15.8K sh | May 15, 2026 traded May 14, 2026 |
| 21 | Reynders John V WDirector, Chief Financial Officer | Option exercise | M | — 15.8K sh | May 15, 2026 traded May 14, 2026 |
| 9 | Reynders John V WDirector, Chief Financial Officer | Grant or award | A | — 33.2K sh | May 15, 2026 traded May 14, 2026 |
| 9 | Bedi ArjunDirector | Option exercise | M | — 5,547 sh | May 15, 2026 traded May 14, 2026 |
| 9 | Anhalt RonaChief Human Resources Officer | Disposition to issuer | D | — 43.9K sh | May 13, 2026 traded May 11, 2026 |
| 24 | Resnick Jon MatthewDirector, Chief Executive Officer | Tax withholding | F | $154K 24.4K sh | May 13, 2026 traded May 11, 2026 |
| 9 | Resnick Jon MatthewDirector, Chief Executive Officer | Grant or award | A | — 268.9K sh | May 13, 2026 traded May 11, 2026 |
| 9 | Resnick Jon MatthewDirector, Chief Executive Officer | Grant or award | A | — 740.7K sh | May 13, 2026 traded May 11, 2026 |
| 9 | Resnick Jon MatthewDirector, Chief Executive Officer | Grant or award | A | — 179.3K sh | May 13, 2026 traded May 11, 2026 |
| 9 | Resnick Jon MatthewDirector, Chief Executive Officer | Grant or award | A | — 493.8K sh | May 13, 2026 traded May 11, 2026 |
| 9 | Resnick Jon MatthewDirector, Chief Executive Officer | Grant or award | A | — 728.4K sh | May 13, 2026 traded May 11, 2026 |
| 21 | Resnick Jon MatthewDirector, Chief Executive Officer | Option exercise | M | — 59.8K sh | May 13, 2026 traded May 11, 2026 |
| 9 | Corcoran DanielSVP and General Counsel | Grant or award | A | — 111.1K sh | May 13, 2026 traded May 11, 2026 |
| 9 | Anhalt RonaChief Human Resources Officer | Grant or award | A | — 43.9K sh | May 13, 2026 traded May 11, 2026 |
| 9 | Anhalt RonaChief Human Resources Officer | Grant or award | A | — 61.7K sh | May 13, 2026 traded May 11, 2026 |
| 9 | Anhalt RonaChief Human Resources Officer | Grant or award | A | — 92.6K sh | May 13, 2026 traded May 11, 2026 |
| 9 | Resnick Jon MatthewDirector, Chief Executive Officer | Option exercise | M | — 59.8K sh | May 13, 2026 traded May 11, 2026 |
| 9 | Corcoran DanielSVP and General Counsel | Disposition to issuer | D | — 48.8K sh | May 13, 2026 traded May 11, 2026 |
| 9 | Corcoran DanielSVP and General Counsel | Grant or award | A | — 48.8K sh | May 13, 2026 traded May 11, 2026 |
| 9 | Corcoran DanielSVP and General Counsel | Grant or award | A | — 74.1K sh | May 13, 2026 traded May 11, 2026 |
| 9 | McKemey AdrianPresident, Drug Dev. Solutions | Option exercise | M | — 10.8K sh | Apr 3, 2026 traded Apr 1, 2026 |
| 17 | McKemey AdrianPresident, Drug Dev. Solutions | Tax withholding | F | $15K 2,642 sh | Apr 3, 2026 traded Apr 1, 2026 |
| 21 | Anhalt RonaChief Human Resources Officer | Option exercise | M | — 9,764 sh | Apr 3, 2026 traded Apr 1, 2026 |
| 17 | Anhalt RonaChief Human Resources Officer | Tax withholding | F | $17K 3,062 sh | Apr 3, 2026 traded Apr 1, 2026 |
| 21 | Corcoran DanielSVP and General Counsel | Option exercise | M | — 10.8K sh | Apr 3, 2026 traded Apr 1, 2026 |
| 21 | McKemey AdrianPresident, Drug Dev. Solutions | Option exercise | M | — 10.8K sh | Apr 3, 2026 traded Apr 1, 2026 |
| 21 | Anhalt RonaChief Human Resources Officer | Option exercise | M | — 9,764 sh | Apr 3, 2026 traded Apr 1, 2026 |
| 17 | Corcoran DanielSVP and General Counsel | Tax withholding | F | $33K 5,751 sh | Apr 3, 2026 traded Apr 1, 2026 |
| 21 | Corcoran DanielSVP and General Counsel | Option exercise | M | — 10.8K sh | Apr 3, 2026 traded Apr 1, 2026 |
| 9 | Bedi ArjunDirector | Grant or award | A | — 5,547 sh | Mar 2, 2026 traded Feb 27, 2026 |